P Trunet

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Medicine, Oncology, Pharmacology +16

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Timothy Iveson, I E Smith, Julie Ahern et al. · PubMed · 1993 · 130 citations

Medicine, Oncology, Pharmacology +16

Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs.

Christian Brun‐Buisson, M Saada, P Trunet et al. · BMJ · 1985 · 90 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +11

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.

Timothy Iveson, Ian E. Smith, Julie Ahern et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 80 citations

Medicine, Endocrinology, Pharmacology +17

COMPARATIVE BIOAVAILABILITY OF LETROZOLE UNDER FED AND FASTING CONDITIONS IN 12 HEALTHY SUBJECTS AFTER A 2·5 MG SINGLE ORAL ADMINISTRATION

A. Sioufi, N. Sandrenan, J. Godbillon et al. · Biopharmaceutics & Drug Disposition · 1997 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +16